The 9th largest veterinary pharmaceutical company in the world and the 4th largest dedicated to animal health, Vetoquinol is first and foremost an independent, family-owned business.

The Vetoquinol Group combines sustainability, growth and independence in an increasingly competitive world market. Committed to the protection and well-being of both animals and people, Vetoquinol creates, develops and sells veterinary drugs and non-medical products all over the world.

The company is widely reputed for its expertise in the fields of infectious diseases, pain and inflammation in livestock (cattle and pigs) and pets (dogs and cats). For over 80 years, Vetoquinol’s pursuit of growth has been underpinned by strong values of team spirit, performance and the sharing of corporate culture and know-how with customers, vets, breeders, partners and employees alike.

Today, with 140 distributors and direct presence in twenty-four countries in Europe, the Americas and Asia-Pacific, Vetoquinol has developed a worldwide “network” with over 2,000 employees.